Version 5.4
Homo sapiens Gene: SPINK13
Summary
InnateDB Gene IDBG-233048.6
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol SPINK13
Gene Name serine peptidase inhibitor, Kazal type 13 (putative)
Synonyms
Species Homo sapiens
Ensembl Gene ENSG00000214510
Encoded Proteins
IDBP-233050
serine peptidase inhibitor, Kazal type 13 (putative)
IDBP-479755
serine peptidase inhibitor, Kazal type 13 (putative)
IDBP-476657
serine peptidase inhibitor, Kazal type 13 (putative)
Protein Structure
Useful resources Stemformatics EHFPI ImmGen
Entrez Gene
Summary Currently no Entrez Summary Available. You might want to check the Summary Sections of the Orthologs.
Gene Information
Type Protein coding
Genomic Location Chromosome 5:148268180-148286254
Strand Forward strand
Band q32
Transcripts
ENST00000398450 ENSP00000381468
ENST00000512953 ENSP00000421048
ENST00000511106 ENSP00000426279
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 1 experimentally validated interaction(s) in this database.
Experimentally validated
Total 1 [view]
Protein-Protein 1 [view]
Protein-DNA 0
Protein-RNA 0
DNA-DNA 0
RNA-RNA 0
DNA-RNA 0
Gene Ontology

Molecular Function
Accession GO Term
GO:0004867 serine-type endopeptidase inhibitor activity
GO:0005515 protein binding
Biological Process
GO:0010951 negative regulation of endopeptidase activity
GO:1902225 negative regulation of acrosome reaction
Cellular Component
GO:0005576 extracellular region
Orthologs
No orthologs found for this gene
Cross-References
SwissProt
TrEMBL
UniProt Splice Variant
Entrez Gene
UniGene Hs.483771
RefSeq NM_001040129
HUGO
OMIM
CCDS CCDS43383
HPRD
IMGT
EMBL
GenPept
RNA Seq Atlas

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca